glp-1 fda approved indications Can Type 1 and Type 2 Diabetes Patients Use Medications GI Adverse Effects of Glucagon-Like

Learn why nutrient-rich foods can naturally elevate GLP-1 levels, aiding in weight management and maintaining blood sugar.

Achieve sustainable weight loss with a plan that supports your medication regimen and dietary needs

Both glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium-glucose cotransporter-2 (SGLT-2) inhibitors can reduce CV risk in patients with T2D, and both are recommended by the American Diabetes Association to reduce the risk of major cardiovascular events (MACE)

This guide explores the clinical evidence, biomarker considerations, and how providers evaluate safety when considering GLP-1 therapy for patients with inflammatory bowel disease